MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer.

@article{Eralp2008MAPKOI,
  title={MAPK overexpression is associated with anthracycline resistance and increased risk for recurrence in patients with triple-negative breast cancer.},
  author={Y. Eralp and D. Derin and Y. Ozluk and E. Yavuz and N. Guney and P. Saip and M. Muslumanoglu and A. İğci and S. K{\"u}ç{\"u}c{\"u}k and M. Dinçer and A. Aydıner and E. Topuz},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2008},
  volume={19 4},
  pages={
          669-74
        }
}
  • Y. Eralp, D. Derin, +9 authors E. Topuz
  • Published 2008
  • Medicine
  • Annals of oncology : official journal of the European Society for Medical Oncology
BACKGROUND Triple-negative breast cancer is estimated to account for 15%-20% of all patients with breast cancer and is considered as a prognostically unfavorable subset. The aim of this study is to evaluate the prognostic impact of various molecular factors in patients with triple-negative breast cancer. PATIENTS AND METHODS Tumor specimens from 109 patients with receptor-negative (estrogen receptor and progesterone receptor) breast cancer were analyzed for mitogen-activated protein kinase… Expand
Activated PI3K/AKT and MAPK pathways are potential good prognostic markers in node-positive, triple-negative breast cancer.
Tyrosine Kinase Inhibitors in Triple Negative Breast Cancer
Triple-negative breast cancer--current status and future directions.
Clinical and molecular predictors of long-term response in HER2 positive metastatic breast cancer patients
Adjuvant therapy of triple negative breast cancer
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 28 REFERENCES
Triple-negative breast cancer: therapeutic options.
Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer.
Basal-like breast carcinomas: clinical outcome and response to chemotherapy
Breast cancer classification and prognosis based on gene expression profiles from a population-based study
  • C. Sotiriou, S. Neo, +7 authors E. Liu
  • Biology, Medicine
  • Proceedings of the National Academy of Sciences of the United States of America
  • 2003
Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome.
...
1
2
3
...